Home›Companies›Biotech & Pharma›Xilis

Xilis, Inc.

Updated Oct 27, 2026·Latest SEC filing Apr 25, 2025·Suggest an edit

About Xilis

Xilis is a private company based in Durham, North Carolina. It has reported $110,769,827 raised in four offerings on Form D since December 2019. Its chief executive is William Smythe.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 10, 2025Apr 25, 2025$19,405,205fully sold9$2.1MEquity, DebtRule 506(b)Form D ↗
Jun 1, 2022Jul 14, 2022$16,514,618fully sold14$1.1MEquityRule 506(b)Form D ↗
Jun 24, 2021Jul 9, 2021$70,000,006fully sold17$4.1MEquityRule 506(b)Form D ↗
Nov 19, 2019Dec 6, 2019amended May 21, 2020$4,849,998fully sold8$606KEquityRule 506(b)Form D/A ↗1 earlier filing
Total, four offerings$110,769,827

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Xilis's Form D filed Apr 25, 2025.

AH
Alaa Halawa
Director
JK
WS
William Smythe
Chief Executive Officer and director

Earlier filings also listed Xiling Shen (chief executive officer and director, last listed Jul 2022), Wesley Chan (executive officer and director, last listed Jul 2022), David Hsu (executive officer and director, last listed Jul 2022) and David Shiaowen (director, last listed May 2020).

Sources

  1. SECXilis, Inc. Form D, filed Dec 6, 2019
  2. SECXilis, Inc. filing history